Jeff Auxier's GILD Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 8,793 shares of Gilead Sciences, Inc. (GILD) worth $1.08 M, representing 0.15% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Jeff Auxier has maintained a long-term strategic position in GILD, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2020, adding 3,703 shares. Largest reduction occurred in Q4 2024, reducing 2,072 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Gilead Sciences (GILD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gilead Sciences (GILD) Trades by Jeff Auxier
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -200 | Reduce 2.22% | 8,793 | $122.74 |
| Q3 2025 | -160 | Reduce 1.75% | 8,993 | $111.00 |
| Q2 2025 | -45 | Reduce 0.49% | 9,153 | $110.87 |
| Q1 2025 | -507 | Reduce 5.22% | 9,198 | $112.05 |
| Q4 2024 | -2,072 | Reduce 17.59% | 9,705 | $92.37 |
| Q3 2024 | -48 | Reduce 0.41% | 11,777 | $83.84 |
| Q2 2024 | -10 | Reduce 0.08% | 11,825 | $68.61 |
| Q1 2024 | -382 | Reduce 3.13% | 11,835 | $73.25 |
| Q4 2023 | -366 | Reduce 2.91% | 12,217 | $81.01 |
| Q3 2023 | -220 | Reduce 1.72% | 12,583 | $74.94 |
| Q2 2023 | -35 | Reduce 0.27% | 12,803 | $77.07 |
| Q1 2023 | -370 | Reduce 2.80% | 12,838 | $82.97 |
| Q4 2022 | -30 | Reduce 0.23% | 13,208 | $85.85 |
| Q3 2022 | -70 | Reduce 0.53% | 13,238 | $61.72 |
| Q1 2022 | -150 | Reduce 1.11% | 13,308 | $59.44 |
| Q4 2021 | -490 | Reduce 3.51% | 13,458 | $72.60 |
| Q2 2021 | -150 | Reduce 1.06% | 13,948 | $68.83 |
| Q4 2020 | -1,355 | Reduce 8.77% | 14,098 | $58.24 |
| Q3 2020 | +3,703 | Add 31.51% | 15,453 | $63.16 |
| Q2 2020 | -50 | Reduce 0.42% | 11,750 | $76.94 |
| Q1 2020 | +1,850 | Add 18.59% | 11,800 | $74.75 |
| Q4 2019 | -100 | Reduce 1.00% | 9,950 | $65.03 |
| Q2 2019 | -1,780 | Reduce 15.05% | 10,050 | $67.56 |
| Q1 2019 | +1,625 | Add 15.92% | 11,830 | $65.00 |
| Q4 2018 | -1,345 | Reduce 11.65% | 10,205 | $62.52 |
| Q3 2018 | +3,075 | Add 36.28% | 11,550 | $77.23 |
| Q2 2018 | +100 | Add 1.19% | 8,475 | $70.80 |
| Q1 2018 | +95 | Add 1.15% | 8,375 | $75.34 |
| Q4 2017 | +150 | Add 1.85% | 8,280 | $71.62 |
| Q3 2017 | +1,357 | Add 20.04% | 8,130 | $81.06 |
| Q2 2017 | +96 | Add 1.44% | 6,773 | $70.72 |
| Q1 2017 | +1,200 | Add 21.91% | 6,677 | $67.99 |
| Q4 2016 | +695 | Add 14.53% | 5,477 | $71.57 |
| Q3 2016 | +1,800 | Add 60.36% | 4,782 | $79.05 |
| Q1 2016 | +700 | Add 30.67% | 2,982 | $91.88 |
| Q4 2015 | +2,282 | New Buy | 2,282 | $101.23 |
Jeff Auxier's Gilead Sciences Investment FAQs
Jeff Auxier first purchased Gilead Sciences, Inc. (GILD) in Q4 2015, acquiring 2,282 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Gilead Sciences, Inc. (GILD) for 41 quarters since Q4 2015.
Jeff Auxier's largest addition to Gilead Sciences, Inc. (GILD) was in Q3 2020, adding 15,453 shares worth $976,000.
According to the latest 13F filing for Q4 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 8,793 shares of Gilead Sciences, Inc. (GILD), valued at approximately $1.08 M.
As of the Q4 2025 filing, Gilead Sciences, Inc. (GILD) represents approximately 0.15% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings.
Jeff Auxier's peak holding in Gilead Sciences, Inc. (GILD) was 15,453 shares, as reported at the end of Q3 2020.